These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11806758)

  • 1. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
    Marks PJ; Neal KR
    BMC Public Health; 2001; 1():16. PubMed ID: 11806758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of the prescribing of chemoprophylaxis to index cases of invasive meningococcal disease.
    Heywood P; Holtby I
    Commun Dis Public Health; 2000 Dec; 3(4):271-3. PubMed ID: 11280257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis fails to prevent a second case of meningococcal disease in a day nursery.
    Cartwright KA; Hunt D; Fox A
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R199. PubMed ID: 8556104
    [No Abstract]   [Full Text] [Related]  

  • 4. The unique role of diamorphine in British medical practice: a survey of general practitioners and hospital doctors.
    Gossop M; Keaney F; Sharma P; Jackson M
    Eur Addict Res; 2005; 11(2):76-82. PubMed ID: 15785068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains.
    Dawson SJ; Fey RE; McNulty CA
    Commun Dis Public Health; 1999 Sep; 2(3):215-6. PubMed ID: 10491880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
    Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD
    Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024.
    Berry I; Rubis AB; Howie RL; Sharma S; Marasini D; Marjuki H; Crowe S; McNamara LA
    MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):99-103. PubMed ID: 38329923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease in a backpackers hostel in Scotland: a risk assessment for prophylaxis.
    Davis LC; Smith KA; Willocks LJ
    Euro Surveill; 2009 Aug; 14(31):. PubMed ID: 19660243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.
    Kristiansen BE; Tveten Y; Jenkins A
    BMJ; 1998 Sep; 317(7159):621-5. PubMed ID: 9727987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.
    Cooke RP; Riordan T; Jones DM; Painter MJ
    BMJ; 1989 Mar; 298(6673):555-8. PubMed ID: 2495111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin].
    González de Aledo Linos A; García Merino J
    An Esp Pediatr; 2000 Nov; 53(5):412-7. PubMed ID: 11521657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia.
    Cutts C; Tett SE
    Eur J Clin Pharmacol; 2003 Mar; 58(11):761-6. PubMed ID: 12634983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prescribing by single handed general practitioners: secondary analysis of data.
    Gill PS; Roalfe A
    J Clin Pharm Ther; 2001 Jun; 26(3):195-9. PubMed ID: 11422603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.
    Purcell B; Samuelsson S; Hahné SJ; Ehrhard I; Heuberger S; Camaroni I; Charlett A; Stuart JM
    BMJ; 2004 Jun; 328(7452):1339. PubMed ID: 15178612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic prophylaxis for bacterial meningitis: overuse and uncertain efficacy.
    Pearson N; Gunnell DJ; Dunn C; Beswick T; Hill A; Ley B
    J Public Health Med; 1995 Dec; 17(4):455-8. PubMed ID: 8639346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Pediatrics; 1996 Mar; 97(3):404-12. PubMed ID: 8604281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections.
    Schwartz B
    Rev Infect Dis; 1991; 13 Suppl 2():S170-3. PubMed ID: 2017647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.